Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 27 citing articles:

Oxidative Stress, Endoplasmic Reticulum Stress and Apoptosis in the Pathology of Alzheimer’s Disease
Bidemi Emmanuel Ekundayo, Tajudeen Olabisi Obafemi, Olusola Bolaji Adewale, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 2, pp. 457-477
Closed Access | Times Cited: 34
Heavy metals exposure and Alzheimer’s disease: Underlying mechanisms and advancing therapeutic approaches
Norah A. Althobaiti
Behavioural Brain Research (2024) Vol. 476, pp. 115212-115212
Closed Access | Times Cited: 11
Proteostasis disruption and senescence in Alzheimer’s disease pathways to neurodegeneration
Riya Thapa, Asif Ahmad Bhat, Moyad Shahwan, et al.
Brain Research (2024) Vol. 1845, pp. 149202-149202
Closed Access | Times Cited: 8
Behavioral and histological study on the neuroprotective effect of thymoquinone on the cerebellum in AlCl3-induced neurotoxicity in rats through modulation of oxidative stress, apoptosis, and autophagy
Amira I. Shrief, Dina S Elshenawy, Ahmed E. Elsukary, et al.
Journal of Molecular Histology (2025) Vol. 56, Iss. 2
Closed Access | Times Cited: 1
Empagliflozin repurposing in Parkinson’s disease; modulation of oxidative stress, neuroinflammation, AMPK/SIRT-1/PGC-1α, and wnt/β-catenin pathways
Noha Nabil Mohammed, Mariane G. Tadros, Mina Y. George
Inflammopharmacology (2023) Vol. 32, Iss. 1, pp. 777-794
Open Access | Times Cited: 20
Empagliflozin Alleviates Carfilzomib-Induced Cardiotoxicity in Mice by Modulating Oxidative Stress, Inflammatory Response, Endoplasmic Reticulum Stress, and Autophagy
Mina Y. George, Mohamed S. Dabour, Eman Rashad, et al.
Antioxidants (2024) Vol. 13, Iss. 6, pp. 671-671
Open Access | Times Cited: 6
Phytochemical profiling and neuroprotective activity of Callistemon subulatus leaves against cyclophosphamide-induced chemobrain
Omyma Rabie, Heba A. S. El‐Nashar, Mina Y. George, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115596-115596
Open Access | Times Cited: 14
Methylated urolithin A, mitigates cognitive impairment by inhibiting NLRP3 inflammasome and ameliorating mitochondrial dysfunction in aging mice
Peng Chen, Yulai Wang, Jing Xie, et al.
Neuropharmacology (2024) Vol. 252, pp. 109950-109950
Closed Access | Times Cited: 5
Lycopene mitigates paclitaxel-induced cognitive impairment in mice; Insights into Nrf2/HO-1, NF-κB/NLRP3, and GRP-78/ATF-6 axes
Nasriah Zakaria, Esther T. Menze, Doaa A. Elsherbiny, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111262-111262
Closed Access
Crafting cationic lecithmer nanocomposites as promising wagons for brain targeting of cinnamaldehyde: Accentuated neuroprotection via downregulation of Aβ1-42/p-tau crosstalk
Amany A. Azouz, Mohammed H. El komy, Mohammed Elmowafy, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106664-106664
Closed Access
Neuromodulatory effect of troxerutin against doxorubicin and cyclophosphamide-induced cognitive impairment in rats: Potential crosstalk between gut–brain and NLRP3 inflammasome axes
Nada K. Gamal, Reem N. El‐Naga, Iriny M. Ayoub, et al.
International Immunopharmacology (2025) Vol. 149, pp. 114216-114216
Closed Access
Quality by design endorsed fabrication of xanthohumol loaded solid nanostructured lipid carrier based powder for effective treatment of Alzheimer's disease in rats
Nikhil Khandale, Devendra Birla, Md. Shahbaz Alam, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106792-106792
Closed Access
Coenzyme Q10 alleviates AlCl3 and D-galactose induced Alzheimer via modulating oxidative burden and TLR-4/MAPK pathways and regulation microRNA in rat brain
Nagat F. Nawar, Doha M. Beltagy, Ehab Tousson, et al.
Toxicology Research (2025) Vol. 14, Iss. 2
Closed Access
The potential neuroprotective effect of empagliflozin against depressive-like behavior induced by chronic unpredictable mild stress in rats: Involvement of NLRP3 inflammasome
Marwa A. Ali, Haidy E. Michel, Esther T. Menze, et al.
European Journal of Pharmacology (2025), pp. 177525-177525
Closed Access
A calmodulin-derived peptide TI-16 inhibits alzheimer's disease progression by decreasing aβ burden and restoring calcium dyshomeostasis
Jingyang Su, Jun Wei, Bowen Zhang, et al.
Bioorganic Chemistry (2025), pp. 108502-108502
Closed Access
Tau proteins and senescent Cells: Targeting aging pathways in Alzheimer’s disease
Mahaveer Singh, Haider Ali, S. Renuka Jyothi, et al.
Brain Research (2024) Vol. 1844, pp. 149165-149165
Closed Access | Times Cited: 2
Therapeutic Effects of a New Bithiophene against Aluminum -Induced Alzheimer’s Disease in a Rat Model: Pathological and Ultrastructural approach
Kholoud AbdEl-Raouf, Monir A. El-Ganzuri, Wael M. El‐Sayed
Tissue and Cell (2024) Vol. 90, pp. 102529-102529
Closed Access | Times Cited: 2
Challenges and possibilities for the qualitative and quantitative analysis of phosphate metabolites
Pei Zhang, Meiyu Gao, Zunjian Zhang, et al.
TrAC Trends in Analytical Chemistry (2024) Vol. 180, pp. 117934-117934
Closed Access | Times Cited: 2
Ellagitannin Component Punicalin Ameliorates Cognitive Dysfunction, Oxidative Stress, and Neuroinflammation via the Inhibition of cGAS‐STING Signaling in the Brain of an Aging Mouse Model
Peng Chen, Zhongyuan Zhang, Jiexin Lei, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 12, pp. 5690-5712
Closed Access | Times Cited: 2
Polypharmacological Potential of Phosphodiesterase 5 Inhibitors for the Treatment of Neurocognitive Disorders
Ashish Kumar, Fred Kim, Dong‐Keun Song, et al.
Aging and Disease (2024)
Open Access | Times Cited: 1
Identification of vilazodone as a novel plasminogen activator inhibitor to overcome Alzheimer's disease through virtual screening, molecular dynamics simulation, and biological evaluation
Wenxiu Sun, Xuan Sheng, Peiru Li, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 9
Closed Access | Times Cited: 1
Promoting proteostasis by cAMP/PKA and cGMP/PKG
Md Salim Ahammed, Xuejun Wang
Trends in Molecular Medicine (2024)
Closed Access | Times Cited: 1
Recent pharmacological insights on abating toxic protein species burden in neurological disorders: Emphasis on 26S proteasome activation
Mahmoud A. Desouky, Haidy E. Michel, Doaa A. Elsherbiny, et al.
Life Sciences (2024) Vol. 359, pp. 123206-123206
Closed Access
Rosiridin Protects Against Aluminum Chloride-Induced Memory Impairment via Modulation of BDNF/NFκB/PI3K/Akt Pathway in Rats
Sana S. Alqarni, Muhammad Afzal, Khalid Saad Alharbi, et al.
Medicina (2024) Vol. 60, Iss. 11, pp. 1812-1812
Open Access
Repositioning Canagliflozin for Mitigation of Aluminium Chloride-Induced Alzheimer’s Disease: Involvement of TXNIP/NLRP3 Inflammasome Axis, Mitochondrial Dysfunction, and SIRT1/HMGB1 Signalling
Hemat A. Elariny, Ahmed M. Kabel, Heba Mohammed Refat M. Selim, et al.
Medicina (2024) Vol. 60, Iss. 11, pp. 1805-1805
Open Access
Page 1 - Next Page

Scroll to top